Aberrant methylation of six genes (SFN, P16, hMLH1, HOXD13, PCDHGB7, and RASSF1a) in serum cfDNA of breast cancer patients in comparison to the healthy subjects and those with benign breast disease. Here, MLH1 is linked to breast fibrocystic disease.